1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsUSAID Development Innovation Ventures (DIV) is sponsored by USAID. DIV is an open innovation program that seeks to fund breakthrough solutions to critical global development challenges. It emphasizes innovation, evidence-building, and scalability.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
## View Grant Opportunity Development Innovation Ventures: Stage 4 Awards Annual Program Statement (APS) Agency for International Development Agency for International Development Document Type:Grants Notice Funding Opportunity Number:7200AA24APS00003 Funding Opportunity Title:Development Innovation Ventures: Stage 4 Awards Annual Program Statement (APS) Opportunity Category:Discretionary Opportunity Category Explanation: Funding Instrument Type:Grant Category of Funding Activity:Science and Technology and other Research and Development Expected Number of Awards: Assistance Listings:98.
001 -- USAID Foreign Assistance for Programs Overseas Cost Sharing or Matching Requirement:No Last Updated Date:Feb 03, 2025 Original Closing Date for Applications:Mar 28, 2025 Current Closing Date for Applications:Feb 03, 2025 Archive Date:Mar 05, 2025 Estimated Total Program Funding: Eligible Applicants:Others (see text field entitled "Additional Information on Eligibility" for clarification) Additional Information on Eligibility:See SECTION C: ELIGIBILITY INFORMATION ## Additional Information Agency Name:Agency for International Development Description:To complement DIV’s ongoing efforts, this Annual Program Statement (APS) is a specific call for DIV’s new “Stage 4 Initiative” to help support the scale-up and integration of “Stage 4 innovations” from the existing DIV portfolio into broader USAID programming and budgets.
Applicants who are interested in applying for DIV’s core funding (Stages 1 through 3 and Evidence Generation grants) should visit www. usaid. gov/div/apply and should not submit a concept note under this APS.
Potential applicants should read the rules below closely regarding the prerequisites for submitting a concept note to an addendum issued under this APS. Link to Additional Information:[](https://www. grants.
gov/search-results-detail/353290) Grantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact:
According to the current listing, eligibility includes: Open to organizations, including non-profits, for-profits, and academic institutions, that propose innovative solutions to development challenges. Confirm the full requirements in the official notice before applying.
The current listing shows up to $15,000,000 (tiered funding: Pilot up to $200K, Testing up to $1.5M, Transitioning to Scale up to $15M, Evidence Generation up to $1.5M). Verify award ceilings, matching requirements, and allowable costs in the official notice.
USAID Development Innovation Ventures (DIV) is funded by USAID. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
USAID closure eliminated 83% of projects and 280,000 jobs worldwide. The fallout reveals hard lessons about federal funding dependency that apply to every grant-funded organization in America.
Read articleThe CDC's Notice of Funding Opportunity CDC-RFA-JG-26-0056, Continuing to Enhance Global Health Security, closes for applications on June 25, 2026, with $75 million on the table and eight cooperative agreements anticipated. The NOFO sits inside an unusually compressed window for global health implementing partners — after the USAID dismantling and the 2025 CDC reorganization, this is one of the largest remaining flexible federal vehicles for outbreak-prevention work executed through bilateral partnerships with foreign health ministries. Here is what the solicitation requires, why the eligibility design favors specific applicant types, and what to do if you are still considering whether to apply.
Read article